August 9, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Current Article

Amgen’s new drug could be a blockbuster

IN THIS ARTICLE

An Amgen researcher in lab that developed the new Lumakras cancer treatment (courtesy photo) In 2018, Amgen got its first green light to administer a new drug called sotorasib to people in clinical trials. Just three years later, that drug, now known as Lumakras, has been approved as a cancer treatment by the U.S. Food…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.